As TLR4 inhibition in vivo was found to protect against hyperammonemia and hyperammonemia-induced liver injury, these data point toward indirect activation of TLR4 during hyperammonemia, for example, through secreted DAMPs. Here, TLR4 is linked to Hyperammonemia.